Benzimidazole derivatives as RLK and ITK inhibitors
Abstract:
The present disclosure is directed to certain inhibitors of RLK and ITK of formula (I), pharmaceutical compositions comprising such compounds, and method of treating diseases mediated by inhibition of RLK and ITK.
Public/Granted literature
Information query
Patent Agency Ranking
0/0